Pathogenic variants in cancer predisposition genes and prostate cancer risk in men of african ancestry

Marco Matejcic, Yesha Patel, Jenna Lilyquist, Chunling Hu, Kun Y. Lee, Rohan D. Gnanaolivu, Steven N. Hart, Eric C. Polley, Siddhartha Yadav, Nicholas J. Boddicker, Raed Samara, Lucy Xia, Xin Sheng, Alexander Lubmawa, Vicky Kiddu, Benon Masaba, Dan Namuguzi, George Mutema, Kuteesa Job, Henry M. DabanjaSue A. Ingles, Lynne Wilkens, Loic Le Marchand, Stephen Watya, Fergus J. Couch, David V. Conti, Christopher A. Haiman

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


PURPOSE In studies of men of European ancestry, rare pathogenic variants in DNA repair pathway genes have been shown to be associated with risk of aggressive prostate cancer. The contribution of rare coding variation to prostate cancer risk in men of African ancestry has not been established. METHODS We sequenced a panel of 19 DNA repair and cancer predisposition genes in 2,453 African American and 1,151 Ugandan cases and controls with prostate cancer. Rare variants were classified as pathogenic or putatively functionally disruptive and examined in association with prostate cancer risk and disease aggressiveness in gene and pathway-level association analyses. RESULTS Pathogenic variants were found in 75 of 2,098 cases (3.6%) and 31 of 1,481 controls (2.1%; odds ratio [OR], 1.82; 95% CI, 1.19 to 2.79; P = .0044), with the association being stronger for more aggressive disease phenotypes (OR, 3.10; 95% CI, 1.54 to 6.23; P = .0022). The highest risks for aggressive disease were observed with pathogenic variants in the ATM, BRCA2, PALB2, and NBN genes, with ORs ranging from approximately 4 to 15 in the combined study sample of African American and Ugandan men. Rare, nonpathogenic, nonsynonymous variants did not have a major impact on risk of overall prostate cancer or disease aggressiveness. CONCLUSION Rare pathogenic variants in DNA repair genes have appreciable effects on risk of aggressive prostate cancer in men of African ancestry. These findings have potential implications for panel testing and risk stratification in this high-risk population.

Original languageEnglish (US)
Pages (from-to)32-43
Number of pages12
JournalJCO Precision Oncology
StatePublished - 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Pathogenic variants in cancer predisposition genes and prostate cancer risk in men of african ancestry'. Together they form a unique fingerprint.

Cite this